Steris (NYSE: STE) reported Q2 EPS of $1.99, $0.17 better than the analyst estimate of $1.82. Revenue for the quarter came in at $1.2 billion versus the consensus estimate of $1.15 billion.

GUIDANCE:

Steris sees FY2022 EPS of $7.60-$7.85, versus the consensus of $7.72.

For earnings history and earnings-related data on Steris (STE) click here.